pharmaceutical · input

Aquaculture Vaccines (Salmon Lice and Bacterial)

Salmon vaccines (ISA, pancreatic disease, furunculosis) and sea lice treatments; Pharmaq (Zoetis) and PHARMAQ Analytiq dominate Atlantic salmon vaccine market; Norway pioneered vaccines replacing antibiotics in 1980s

4

Source countries

4

Companies

1

Goods affected

0

Claims on record

What depends on it

Goods that need this input

1 essential American goods rely on aquaculture vaccines (salmon lice and bacterial) somewhere upstream in their supply chain.

Where it comes from

Source countries

Share of global supply, by country.

CountryShare of supply
NONorway55%
USUnited States20%
CLChile10%
GBUnited Kingdom8%

Who makes it

Supplier companies

4 companies produce aquaculture vaccines (salmon lice and bacterial).

Zoetis Inc.(ZTS)

HQ US48% share

Zoetis Inc. (NYSE: ZTS; ~$8.5B revenue; Parsippany NJ) is the world's largest animal health company, spun off from Pfizer in 2013. Zoetis manufactures TROVAC-NDV and conventional inactivated AI vaccines for commercial poultry, along with broad-spectrum animal health products for livestock and companion animals across 100 countries.

Merck Animal Health (MSD Animal Health)(MRK)

HQ US32% share

Merck Animal Health (Madison NJ; division of Merck & Co.; ~$5.5B revenue) manufactures AviPro brand avian influenza and Newcastle disease vaccines for commercial poultry. Products sold as MSD Animal Health outside North America. Merck Animal Health is the third-largest animal health company globally. De Soto KS biologics manufacturing site.

Benchmark Animal Health

HQ GB10% share

UK-listed animal health company specializing in aquaculture; produces vaccines, health products, and genetic improvements for salmon and shrimp. Known for Salmosan (azamethiphos) sea lice treatment and Salmobreed/Stofnfiskur salmon breeding programs.

HIPRA

HQ ES5% share

HIPRA (Amer, Girona Catalonia Spain; private; ~€500M estimated revenue) is a European-focused animal health company with strong dairy vaccine and reproductive pharmaceutical product lines. Dairy-relevant products include: HIPRABOVIS (bovine respiratory disease vaccine complex), FERTILINE (GnRH analog — gonadorelin — for dairy reproductive synchronization protocols), FERTAGYL/HIPRELIN (GnRH analog products for reproductive induction in dairy herds), and Pyrocalma (antipyretic for cattle). HIPRA is the leading European dairy reproductive hormone supplier outside the major US and German companies. HIPRA's gonadorelin products compete directly with Zoetis's Cystorelin (gonadorelin) and Elanco's Factrel (gonadorelin) in EU dairy operations. HIPRA's human vaccine division (COVID-19 mRNA vaccine PHH-1V) gained global attention in 2022-2023 — revealing that this primarily-dairy-pharmaceutical Spanish company had independently developed a human COVID vaccine using the same immunology research infrastructure.